| Date Filed | Type | Description |
| 06/30/2023 |
4
| Wang Theodore T (Director) has filed a Form 4 on MariaDB plc|
Txns:
| Granted 182,291 shares
@ $0 |
|
| 06/09/2023 |
4
| Wang Theodore T (Director) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Granted 14,607 options to buy
@ $0.8264, valued at
$12.1k
|
|
| 06/07/2023 |
4
| Puissance Life Science Opportunities Fund VI (10% Owner) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Sold 134,421 shares
@ $0.83, valued at
$111.6k
|
|
| 05/19/2023 |
4
| Puissance Life Science Opportunities Fund VI (10% Owner) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Sold 560,000 shares
@ $9.46, valued at
$5.3M
|
|
| 05/15/2023 |
4
| Wang Theodore T (Director) has filed a Form 4 on MariaDB plc|
Txns:
| Granted 48,342 shares
@ $0 |
|
| 02/14/2023 |
4
| Wang Theodore T (10% Owner) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Granted 29,000 options to buy
@ $1.52, valued at
$44.1k
|
|
| 12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/19/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/02/2022 |
4
| Xie Shihuang (10% Owner) has filed a Form 4 on Angel Pond Holdings Corp|
Txns:
| Disposed of options to buy
@ $0 |
|
| 01/04/2022 |
4
| Wang Theodore T (10% Owner) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Granted 21,828 options to buy
@ $3.1, valued at
$67.7k
|
|
| 07/07/2021 |
4
| Xie Shihuang (CEO) has filed a Form 4 on Angel Pond Holdings Corp|
Txns:
| Disposed of 549,630 options to buy
@ $0 |
|
| 06/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2021 |
4
| Xie Shihuang (CEO) has filed a Form 4 on Angel Pond Holdings Corp|
Txns:
| Disposed of 1,437,500 options to buy
@ $0 |
|
| 05/11/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/12/2020 |
4
| Wang Theodore T (Director) has filed a Form 4 on EKSO BIONICS HOLDINGS, INC.|
Txns:
| Disposed of 744,572 shares
@ $0 |
|
| 09/14/2020 |
4
| Wang Theodore T (10% Owner) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Granted 6,509 options to buy
@ $10.12, valued at
$65.9k
|
|
| 07/27/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2020 |
4
| Wang Theodore T (10% Owner) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Bought 4,986 shares
@ $12.724, valued at
$63.4k
Bought 2,600 shares
@ $12.867, valued at
$33.5k
|
|
| 05/22/2020 |
4
| Puissance Life Science Opportunities Fund VI (10% Owner) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Granted 1,153,846 shares
@ $13, valued at
$15M
|
|
| 04/20/2020 |
4
| Puissance Cross-Border Opportunities III LLC (10% Owner) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Disposed of 553,250 shares
@ $0 |
|
| 03/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/21/2020 |
4
| Wang Theodore T (10% Owner) has filed a Form 4 on EKSO BIONICS HOLDINGS, INC.|
Txns:
| Granted 19,445 shares
@ $0.45, valued at
$8.8k
Granted 136,496 options to buy
@ $0.38, valued at
$51.9k
|
|
| 12/11/2019 |
4
| Puissance Cross-Border Opportunities V LLC (10% Owner) has filed a Form 4 on Tracon Pharmaceuticals, Inc.|
Txns:
| Sold 43,996 shares
@ $3.05, valued at
$134.2k
Sold 340,134 shares
@ $2.92, valued at
$993.2k
|
|
| 11/25/2019 |
4
| Wang Theodore T (10% Owner) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Bought 200 shares
@ $0.37, valued at
$74
Bought 1,050 shares
@ $0.3748, valued at
$393.5
Bought 7,193 shares
@ $0.3856, valued at
$2.8k
|
|
| 09/30/2019 |
4
| Wang Theodore T (10% Owner) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Granted 46,266 options to buy
@ $0.5, valued at
$23.1k
|
|
| 06/14/2019 |
4
| Wang Theodore T (10% Owner) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Bought 50,000 shares
@ $0.6381, valued at
$31.9k
|
|
| 05/24/2019 |
4
| Wang Theodore T (10% Owner) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Bought 27,500 shares
@ $0.6012, valued at
$16.5k
|
|
| 05/22/2019 |
4
| Wang Theodore T (10% Owner) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Bought 43,280 shares
@ $0.6093, valued at
$26.4k
|
|
| 01/25/2019 |
4
| Wang Theodore T (10% Owner) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Bought 450,000 shares
@ $0.7, valued at
$315k
|
|
| 01/03/2019 |
4
| Wang Theodore T (Director) has filed a Form 4 on ViewRay, Inc.|
Txns:
| Granted 7,305 shares
@ $6.16, valued at
$45k
Granted 18,668 shares
@ $0 |
|
| 12/26/2018 |
4
| Wang Theodore T (Director) has filed a Form 4 on ViewRay, Inc.|
Txns:
| Granted 19,116 options to buy
@ $5.21, valued at
$99.6k
|
|
| 12/03/2018 |
4/A
| Puissance Cross-Border Opportunities V LLC (10% Owner) has filed a Form 4 on Tracon Pharmaceuticals, Inc.|
Txns:
| Bought 4,326 shares
@ $1.13, valued at
$4.9k
Sold 4,326 shares
@ $1.21, valued at
$5.2k
|
|
|